Altimmune, Inc.ALTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.9%
5Y CAGR+16.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+17.9%/yr
vs +15.1%/yr prior
5Y CAGR
+16.3%/yr
Consistent
Acceleration
+2.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$28.10M+34.0%
2024$20.97M+15.6%
2023$18.14M+5.9%
2022$17.13M+11.2%
2021$15.41M+16.7%
2020$13.21M+55.4%
2019$8.50M-13.0%
2018$9.77M+15.5%
2017$8.46M-26.6%
2016$11.52M-